The Agency for Healthcare Research and Quality (AHRQ) has funded a large, 3-year study at the University of North Carolina (UNC) to examine the comparative effectiveness of prostate cancer treatments. This is a prospective cohort study of over 1,000 patients in North Carolina who will complete surveys at baseline (pre-treatment) and then prospectively during follow-up. There are few patients treated with Cyberknife radiation therapy in the state of North Carolina, so this treatment modality will not be fully examined in the cohort study. The Cyberknife robotic radiosurgery for prostate cancer “parallel study” is a collaboration with other institutions across the United States to enroll 100 patients onto a prospective cohort, who will be followed using identical methods as the North Carolina cohort. This will allow comparisons of quality of life, disease control and survival of patients treated with this newer treatment modality against those of other treatments.
Principal Investigator: Ronald Chen
Funding: Accuray Incorporated
Total Project Period: 06/01/12-05/31/13